Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for COVID-19 Outpatients
NCT04311177Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Apr 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Losartan with Placebo (2 arms). Primary endpoint: Percentage of Participants Admitted to the Hospital at 15 days. Started Apr 2020; status: completed.
02
Drugs
losartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04311177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04311177.